BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesBrandPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsNHS National Framework Agreement for Generic Pharmaceuticals - Wave 16a
    Awarded contract

    NHS National Framework Agreement for Generic Pharmaceuticals - Wave 16a

    Awarded
    £429.9m
    Published 1 Sept 2026

    Nationwide NHS framework for supplying generic pharmaceutical products across multiple regions in three product categories, commencing February 2027 with terms ranging from 8 to 40 months.

    🇬🇧United Kingdom· LondonPublished 1 Sept 2026· 1 months agoviaFind a Tender
    Awarded
    £429.9m
    Published 1 Sept 2026

    Decision brief

    4 fields
    • Contract value
      £429,887,402
      Pounds sterling
    • Closing date
      Not published
      No closing date published
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇬🇧United Kingdom
      London

    Suppliers

    102 suppliers
    • AP
      ASPIRE PHARMA LIMITED
    Lead contractor
  1. ML
    MACARTHYS LABORATORIES LIMITED
    Consortium partner
  2. VP
    VANTAGE PHARMACEUTICALS LTD
    Consortium partner
  3. MI
    Milpharm Limited
    Consortium partner
  4. AP
    Arcadia Pharma Limited
    Consortium partner
  5. PM
    PARI MEDICAL LIMITED
    Consortium partner
  6. RJ
    Reig Jofre UK Ltd
    Consortium partner
  7. HP
    Hikma Pharmaceuticals International Ltd
    Consortium partner
  8. GP
    GALVANY PHARMA LIMITED
    Consortium partner
  9. NS
    Necessity Supplies Ltd
    Consortium partner
  10. SP
    STRIDES PHARMA UK LTD
    Consortium partner
  11. ML
    MSN LABORATORIES EUROPE LIMITED
    Consortium partner
  12. OU
    ORIFARM UK LTD
    Consortium partner
  13. FA
    FLEXIPHARM AUSTRADING LIMITED
    Consortium partner
  14. SP
    SEACROSS PHARMACEUTICALS LTD
    Consortium partner
  15. TP
    THEA PHARMACEUTICALS LIMITED
    Consortium partner
  16. RB
    ROVI BIOTECH LIMITED
    Consortium partner
  17. BP
    BRANCASTER PHARMA LIMITED
    Consortium partner
  18. NO
    Novumgen Limited
    Consortium partner
  19. PF
    PIERRE FABRE LIMITED
    Consortium partner
  20. NP
    NORTHUMBRIA PHARMA THROMBOSIS LIMITED
    Consortium partner
  21. AP
    AFT Pharma UK Limited
    Consortium partner
  22. BH
    Baxter Healthcare Ltd
    Consortium partner
  23. SP
    SYNCHRONY PHARMA
    Consortium partner
  24. ME
    Medreich PLC
    Consortium partner
  25. KP
    KENT PHARMA UK LIMITED
    Consortium partner
  26. OP
    OTSUKA PHARMACEUTICALS (U.K.) LTD.
    Consortium partner
  27. AP
    ASPEN PHARMACARE UK LIMITED
    Consortium partner
  28. AL
    Ascot Laboratories
    Consortium partner
  29. MP
    MACURE PHARMA UK LIMITED
    Consortium partner
  30. MP
    MACLEODS PHARMA UK LIMITED
    Consortium partner
  31. CP
    Celix Pharma
    Consortium partner
  32. BB
    B BRAUN MEDICAL LIMITED
    Consortium partner
  33. GS
    Gilead Sciences Ltd
    Consortium partner
  34. LU
    Lundbeck Ltd
    Consortium partner
  35. PC
    PIRAMAL CRITICAL CARE LIMITED
    Consortium partner
  36. TP
    TORRENT PHARMA (UK) LTD
    Consortium partner
  37. MP
    Medac Pharma LLP
    Consortium partner
  38. CH
    CLINIGEN HEALTHCARE LIMITED
    Consortium partner
  39. BB
    BROWN & BURK UK LIMITED
    Consortium partner
  40. DR
    DR REDDY'S LABORATORIES (UK) LIMITED
    Consortium partner
  41. AL
    ASCEND LABORATORIES (UK) LIMITED
    Consortium partner
  42. NP
    NOVARTIS PHARMACEUTICALS UK LIMITED
    Consortium partner
  43. RP
    RPH Pharma Ltd
    Consortium partner
  44. GK
    Grindeks Kalceks UK Ltd
    Consortium partner
  45. ZP
    ZYDUS PHARMACEUTICALS UK LTD
    Consortium partner
  46. UU
    USV UK LIMITED
    Consortium partner
  47. TR
    THORNTON & ROSS LIMITED
    Consortium partner
  48. PU
    PROVEPHARM UK LTD
    Consortium partner
  49. PF
    Pfizer Limited
    Consortium partner
  50. PU
    PANPHARMA UK LIMITED
    Consortium partner
  51. MP
    Mercury Pharmaceuticals Limited
    Consortium partner
  52. DP
    DESITIN PHARMA LIMITED
    Consortium partner
  53. FP
    FARMAK PHARMACEUTICALS UK LTD
    Consortium partner
  54. DR
    DRUGSRUS LTD
    Consortium partner
  55. PL
    Phoenix labs U.C.
    Consortium partner
  56. GP
    GENNISIUM PHARMA
    Consortium partner
  57. AC
    Accord-UK Ltd
    Consortium partner
  58. GP
    Glenmark Pharmaceuticals Europe Ltd
    Consortium partner
  59. VU
    Viatris UK Healthcare Limited
    Consortium partner
  60. TU
    Teva UK Limited
    Consortium partner
  61. SP
    SVP Pharma Ltd
    Consortium partner
  62. TP
    Torbay Pharmaceuticals
    Consortium partner
  63. SA
    Sandoz
    Consortium partner
  64. EH
    ENNOGEN HEALTHCARE INTERNATIONAL LIMITED
    Consortium partner
  65. EU
    ERAMOL (UK) Limited
    Consortium partner
  66. NU
    NEURAXPHARM UK LIMITED
    Consortium partner
  67. MP
    Morningside Pharmaceuticals Limited
    Consortium partner
  68. SE
    SERB LTD
    Consortium partner
  69. CH
    Chiesi Limited
    Consortium partner
  70. CH
    CONSILIENT HEALTH (UK) LIMITED
    Consortium partner
  71. FP
    Flynn Pharma
    Consortium partner
  72. GU
    GLAXOSMITHKLINE UK LIMITED
    Consortium partner
  73. AP
    AGB Pharma (UK) Ltd
    Consortium partner
  74. WU
    Wockhardt UK Limited
    Consortium partner
  75. FP
    FERRING PHARMACEUTICALS LTD
    Consortium partner
  76. NH
    Neon Healthcare
    Consortium partner
  77. RP
    RIDGE PHARMA LIMITED
    Consortium partner
  78. HP
    hameln pharma ltd
    Consortium partner
  79. FK
    FRESENIUS KABI
    Consortium partner
  80. AO
    AOP Orphan Limited
    Consortium partner
  81. FH
    FONTUS HEALTH LTD
    Consortium partner
  82. BI
    Bowmed Ibisqus Limited
    Consortium partner
  83. TL
    Tillomed Laboratories Ltd
    Consortium partner
  84. CP
    Crescent Pharma Limited
    Consortium partner
  85. UP
    UNICORN PHARMACEUTICALS LIMITED
    Consortium partner
  86. BP
    Biocon Pharma UK Limited
    Consortium partner
  87. AM
    Amarox Limited
    Consortium partner
  88. TU
    Takeda UK Limited
    Consortium partner
  89. AG
    Aguettant Limited
    Consortium partner
  90. DL
    DAY LEWIS MEDICAL LIMITED
    Consortium partner
  91. WA
    WAYMADE PLC
    Consortium partner
  92. SP
    SUN PHARMA UK LIMITED
    Consortium partner
  93. CP
    Colonis Pharma Ltd
    Consortium partner
  94. CE
    CIPLA (EU) LIMITED
    Consortium partner
  95. CS
    C. S. T. PHARMA LIMITED
    Consortium partner
  96. RP
    Roche Products Ltd
    Consortium partner
  97. LG
    Lipomed GmbH
    Consortium partner
  98. PP
    Perennial Pharma Ltd
    Consortium partner
  99. SS
    Selective Supplies Ltd
    Consortium partner
  100. EP
    Esteve Pharmaceuticals Limited
    Consortium partner
  101. ZP
    Zentiva Pharma UK Ltd
    Consortium partner
  102. Lifecycle

    Awarded

    Contract awarded. Originally published 1 months ago.

    1 September 2026
    Awarded — no open tender advertised

    Brief

    This is a national framework agreement for the supply of generic pharmaceutical products across the NHS. The framework is divided into three product categories with varying call-off periods and regional allocations: (1) Oral and non-parenteral products for Central and South West, London and South East, and North West and London regions (40 months from February 2027 to May 2030); (2) Hospital-only products for Deanery Level Networks and North West regions (24 months from February 2027 to January 2029); and (3) Hospital-only housekeeping products for Central and East, South West, London and South East, and North East regions (8-16 months starting February 2027). The framework agreement may be extended at the NHS authority's discretion for additional periods totaling up to 48 months. Offer reference: CM/PHG/24/5714.

    Track record

    7 awards · 6 winners
    Open panel

    Mostly framework call-offs rather than head-to-head competition.

    In healthcare medical, NHS ENGLAND has awarded 7 contracts to 6 suppliers.

    Who wins here
    1. ASPIRE PHARMA LIMITED2× · 29%
    2. Amgen Ltd1× · 14%
    3. IMMUNOIVD AB1× · 14%
    4. AVENTIS PHARMA LIMITED t-a Sanofi1× · 14%
    5. ImmunoIVD1× · 14%
    6. Zentiva Pharma UK Ltd1× · 14%

    Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

    More from NHS ENGLAND

    4 listingsView all →
    Professional Services🇬🇧United Kingdom

    Quality Assurance and Improvement of GP Training Modules

    Procurement to improve and assure the quality of GP specialty training modules to enhance trainee capacity and curriculum delivery.

    est.£98,000NHS ENGLAND
    Published 12 Oct 2026
    AwardedIT & Software🇬🇧United Kingdom

    NHS Digital Operational Pressures Dashboard Maintenance and Expansion

    Maintain and expand the NHS national digital dashboard that tracks operational pressure levels across urgent and emergency care services.

    £400,000NHS ENGLAND
    Published 12 Oct 2026
    AwardedIT & Software🇬🇧United Kingdom

    NHS Digital Operational Pressure Monitoring Dashboard Support

    Maintain and enhance the NHS national digital dashboard for monitoring emergency care operational pressures across England.

    £400,000NHS ENGLAND
    Published 12 Oct 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    NHS Pulsed Field Ablation Strategy Consultation

    The NHS seeks supplier feedback on Pulsed Field Ablation technology and services for treating Atrial Fibrillation to develop its procurement strategy.

    £1nominalNHS ENGLAND
    Published 9 Oct 2026

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Research Training Fellowship for Healthcare Professionals

    A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.

    Medical Research Council (MRC)
    Published 21 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Dental Implants, Digital Services and Associated Products Supply

    NHS Greater Glasgow & Clyde seeks experienced dental implant and digital services suppliers across multiple lots with automatic innovation lot qualification.

    NHS Greater Glasgow and Clyde
    Published 12 Oct 2026
    Healthcare & Medical🇬🇧United Kingdom

    Supply of Intraosseous Devices and Associated Spares

    Framework agreement for supply of intraosseous devices and spares to the UK Ministry of Defence, valued at £4-6 million over 4 years.

    est.£6,000,000Leidos Supply Limited
    Published 12 Oct 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    Smoking Cessation Services for Homeless Populations in Fenland

    Cambridgeshire County Council seeks providers to deliver smoking cessation services for homeless and socially excluded populations in Fenland under the Provider Selection Regime.

    £375,000indicativeCAMBRIDGESHIRE COUNTY COUNCIL
    Published 12 Oct 2026
    Take action
    View on sourceFind a Tender

    Award notice and full record on the publisher's site

    Publisher
    UK Cabinet Office
    Licence
    OGL v3.0
    Source
    find-tender.service.gov.uk
    Record ID
    ocds-h6vhtk-051c3a

    Your fit

    Could you win the next one?

    This went to ASPIRE PHARMA LIMITED. Sonar reads NHS ENGLAND's work like this against your business — who holds it, and whether you could compete or partner next time.

    Check my fit

    Free · Matches every Monday

    NE
    Buyer
    NHS ENGLAND
    Sector
    Healthcare & Medical